ChEMBL: Bioactive data for drug discovery

ChEMBL, a database of bioactive compounds, provides curated bioactivity data quantitatively linking compounds to molecular targets, phenotypic effects, exposure and toxicity end-points. ChEMBL focuses on interactions relevant to medicinal chemistry, clinical development and therapeutics data. Pharmaceutically important gene families in ChEMBL can be viewed in the GPCR and Kinase SARfari web portals.

Team members

John P. Overington
Nathan Dedman
Francis Atkinson
Louisa Bellis
Mark Davies
Jon Chambers